GENNEX LABORATORIES
Back to Balance Sheet
|
GENNEX LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹256 Cr | ₹230 Cr | ₹132 Cr | ₹68 Cr | ₹59 Cr |
What is the latest Total Liabilities ratio of GENNEX LABORATORIES ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹256 Cr |
| Mar2024 | ₹230 Cr |
| Mar2023 | ₹132 Cr |
| Mar2022 | ₹68 Cr |
| Mar2021 | ₹59 Cr |
How is Total Liabilities of GENNEX LABORATORIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹256 Cr | 11.36 | |
| Mar2024 | ₹230 Cr | 73.82 | |
| Mar2023 | ₹132 Cr | 94.30 | |
| Mar2022 | ₹68 Cr | 15.49 | |
| Mar2021 | ₹59 Cr | - | |
Compare Total Liabilities of peers of GENNEX LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GENNEX LABORATORIES | ₹254.8 Cr | -2.9% | -4.2% | -18.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,794.0 Cr | 1.7% | -2.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,956.0 Cr | 2% | -2.2% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,820.0 Cr | -1.8% | -0.1% | 36.7% | Stock Analytics | |
| CIPLA | ₹109,370.0 Cr | -2% | -3.3% | -9.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,133.0 Cr | -0.6% | -3.8% | -6.9% | Stock Analytics | |
GENNEX LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENNEX LABORATORIES | -2.9% |
-4.2% |
-18.2% |
| SENSEX | 1.7% |
2.1% |
-6% |
You may also like the below Video Courses